Cargando…
High-dose rate brachytherapy in localized penile cancer: 5-Year clinical outcome analysis
PURPOSE: To analyze the oncological outcome and toxicity profile after conservative treatment based on multicatheter interstitial high-dose rate brachytherapy (MHB) for patients presenting a localized penile cancer. MATERIALS AND METHODS: Patients with histologically proven, non-metastatic (T1-T2 N0...
Autores principales: | Martz, Nicolas, Bodokh, Yohan, Gautier, Mathieu, Thamphya, Brice, Schiappa, Renaud, Lam Cham Kee, Daniel, Chevallier, Daniel, Hannoun, Arthur, Chand, Marie-Eve, Hannoun-Levi, Jean-Michel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841215/ https://www.ncbi.nlm.nih.gov/pubmed/33537466 http://dx.doi.org/10.1016/j.ctro.2020.12.008 |
Ejemplares similares
-
High-dose-rate brachytherapy boost for locally advanced cervical cancer: Oncological outcome and toxicity analysis of 4 fractionation schemes
por: le Guyader, Maud, et al.
Publicado: (2021) -
Brachytherapy for oligometastatic prostate cancer to the penis
por: Martz, Nicolas, et al.
Publicado: (2021) -
High-dose rate brachytherapy in localized penile cancer: short-term clinical outcome analysis
por: Rouscoff, Yohann, et al.
Publicado: (2014) -
Single fraction of HDR brachytherapy for prostate cancer: Results of the SiFEPI phase II prospective trial
por: Hannoun-Levi, Jean-Michel, et al.
Publicado: (2022) -
High-dose-rate brachytherapy boost for elderly patients with intermediate to high-risk prostate cancer: 5-year clinical outcome of the PROSTAGE cohort
por: Marotte, Delphine, et al.
Publicado: (2022)